SETH H.Z. FISCHER
Profile
First Name
: SETH
Middle Name
: H.Z.
Last Name
: FISCHER
Related Companies
Titles
Company Name
Related People
DIRECTOR
AL ALTOMARI, RUSSELL W. AYRES, DARIA O. BLACKWELL, SCOTT COIANTE, SCOTT M. COIANTE, ROBERT G. CONWAY, ELIZABETH GARNER, GEOFFREY P. GILMORE, KAREN HONG, JOHN HUBBARD, DEVANG V. KANTESARIA, ABHIJEET LELE, KATIE MACFARLANE, WILLIAM T. MCKEE, DEAN MILLER, LORENZO PELLEGRINI, THOMAS M. ROSSI, ANDREW SCHIFF, ANDREW N. SCHIFF, PAUL J. SCHMITT, AJIT S. SHETTY, JOYCE TSANG, JAMES TURSI, JAMES P. TURSI
DIRECTOR
SANTIAGO ARROYO, M.D., PH.D., CHARLES AUSTIN, ALAN BARBER, STEPHEN BLOCH, STEPHEN BLOCH, M.D., SCOTT BRAUNSTEIN, M.D., SCOTT BRAUNSTEIN, MD, ENRIQUE J. CARRAZANA, MD, CHRISTOPHER M. CASHMAN, MICHAEL R. DOUGHERTY, ELAN EZICKSON, ANTON GOPKA, JOSEPH HULIHAN, M.D., JOE HULIHAN, MD, JOHN KRAYACICH, MARTHA MANNING, ESQ., TIM M. MAYLEBEN, TIMOTHY MAYLEBEN, TIMOTHY M. MAYLEBEN, ANAND MEHRA, ANAND MEHRA, M.D., SARASWATHY NOCHUR, PH.D., HARRY PENNER, HARRY H. PENNER, JR., STEVEN E. PFANSTIEL, HARRY T. REIN, KENNETH SHAW, EDWARD F. SMITH, CABLE STUART, NICOLE VITULLO
DIRECTOR
SANTIAGO ARROYO, M.D., PH.D., CHARLES AUSTIN, ALAN BARBER, STEPHEN BLOCH, STEPHEN BLOCH, M.D., SCOTT BRAUNSTEIN, M.D., SCOTT BRAUNSTEIN, MD, ENRIQUE J. CARRAZANA, MD, CHRISTOPHER M. CASHMAN, MICHAEL R. DOUGHERTY, ELAN EZICKSON, ANTON GOPKA, JOSEPH HULIHAN, M.D., JOE HULIHAN, MD, JOHN KRAYACICH, MARTHA MANNING, ESQ., TIM M. MAYLEBEN, TIMOTHY MAYLEBEN, TIMOTHY M. MAYLEBEN, ANAND MEHRA, ANAND MEHRA, M.D., SARASWATHY NOCHUR, PH.D., HARRY PENNER, HARRY H. PENNER, JR., STEVEN E. PFANSTIEL, HARRY T. REIN, KENNETH SHAW, EDWARD F. SMITH, CABLE STUART, NICOLE VITULLO
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-03-29
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-12-11
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-03-04
